Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis

Treatments for brain metastases from EGFR/ALK-negative/unselected NSCLC: A network meta-analysis

More clinical evidence is needed regarding the relative priority of treatments for brain metastases (BMs) from EGFR/ALK-negative/unselected non-small cell lung cancer (NSCLC). PubMed, EMBASE, Web of Science, Cochrane Library, and ClinicalTrials.gov databases were searched. Overall survival (OS), cen...

Full description

Bibliographic Details
Main Authors: Zhang Chengkai, Zhou Wenjianlong, Zhang Dainan, Ma Shunchang, Wang Xi, Jia Wang, Guan Xiudong, Qian Ke
Format: Article
Language:English
Published: De Gruyter 2023-02-01
Series:Open Medicine
Subjects:
bayesian network meta-analysis
non-small cell lung cancer
brain metastasis
immunotherapy
radiotherapy
Online Access:https://doi.org/10.1515/med-2022-0574

Internet

https://doi.org/10.1515/med-2022-0574

Similar Items